Manager The Stock Exchange of Thailand According to the resolution of the meeting of the Board of Directors No.3/2019 of Wattanapat Hospital Trang Public Company Limited (“the Company”) held on 9 May 2019
Page 1 No. CMC Sor Lor.009/2019 May 14, 2019 Re: Management Discussion & Analysis for the Period Ended 31 March 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
: President The Stock Exchange of Thailand Pursuant to JAS Asset Public Company Limited (“the Company”) Meeting Resolution No. 6/2019 on 6 August 2019, the resolution to certify the Company’s financial
2nd quarter ended 30 June 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 2nd quarter ended 30 June 2019, as submitted by the Company
Management Discussion and Analysis, Q2/2018 Page1/4 Ref. IR61/12 10 August 2018 Subject: Management Discussion and Analysis, 2nd Quarter Ending 30 June 2018 To : President Stock Exchange of Thailand
Thailand Pursuant to Jaymart Public Company Limited (“the Company”) Board of Directors’ Meeting No. 4/2018 on 10 August 2018, the resolution to certify the financial statements and performance of the Company
Page 1 No. CMC Sor Lor.012/2019 August 13, 2019 Re: Management Discussion & Analysis for the Period Ended 30 June 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03
บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอเมืองสมุทรสำคร จังหวัดสมุทรสำคร 74000 111 Moo 2 Tambon Thachin,Amphur Muangsamutsakhon,Samutsakhon 74000,Thailand. No. DOD 160